Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GLPGF - Amyris Patent Lawsuit And Other News: The Good Bad And Ugly Of Biopharma


GLPGF - Amyris Patent Lawsuit And Other News: The Good Bad And Ugly Of Biopharma

Amyris Inc. suffers a setback over patent lawsuit

Amyris Inc. (AMRS) has been hit by a patent lawsuit instituted by Lavvan Inc. The $881 million lawsuit has been filed in the United States District Court for the Southern District of New York. Both the companies had inked a Research, Collaboration and License Agreement in March 2019 while Lavvan made the initial payment in May 2019.

As per the communique released by Lavvan, the company is seeking damages for Amyris's misappropriation of trade secrets. It is also holding Amyris responsible for patent infringement. The

Read more ...

Stock Information

Company Name: Galapagos Genomics Ord
Stock Symbol: GLPGF
Market: OTC
Website: glpg.com

Menu

GLPGF GLPGF Quote GLPGF Short GLPGF News GLPGF Articles GLPGF Message Board
Get GLPGF Alerts

News, Short Squeeze, Breakout and More Instantly...